1. Home
  2. KLXE vs EVAX Comparison

KLXE vs EVAX Comparison

Compare KLXE & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$2.68

Market Cap

44.8M

Sector

Energy

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$4.25

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLXE
EVAX
Founded
2018
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8M
27.4M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
KLXE
EVAX
Price
$2.68
$4.25
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
265.9K
26.0K
Earning Date
06-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$636,600,000.00
N/A
Revenue This Year
$3.31
N/A
Revenue Next Year
$4.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$1.20
52 Week High
$4.36
$12.15

Technical Indicators

Market Signals
Indicator
KLXE
EVAX
Relative Strength Index (RSI) 53.71 64.00
Support Level $1.61 $2.70
Resistance Level $3.06 $5.48
Average True Range (ATR) 0.32 0.32
MACD 0.00 0.16
Stochastic Oscillator 48.95 76.06

Price Performance

Historical Comparison
KLXE
EVAX

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: